Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
188.73
+2.54 (1.36%)
Nov 22, 2024, 4:00 PM EST - Market closed
Company Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Inspire Medical Systems, Inc.
| Country | United States |
| Founded | 2007 |
| IPO Date | May 3, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,011 |
| CEO | Timothy Herbert |
Contact Details
Address: 5500 Wayzata Blvd., Suite 1600 Golden Valley, Minnesota 55416 United States | |
| Phone | 844 672 4357 |
| Website | inspiresleep.com |
Stock Details
| Ticker Symbol | INSP |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001609550 |
| CUSIP Number | 457730109 |
| ISIN Number | US4577301090 |
| Employer ID | 26-1377674 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Timothy P. Herbert | Founder, Chairman, Chief Executive Officer and President |
| Richard J. Buchholz | Chief Financial Officer |
| Randall A. Ban | Chief Commercial Officer |
| Dr. Charisse Y. Sparks FAAOS, M.D. | Chief Medical Officer |
| Carlton W. Weatherby | Chief Strategy Officer |
| John C. Rondoni | Chief Technology Officer |
| Ezgi Yagci | Vice President of Investor Relations |
| Melissa J. Mann | Chief People Officer |
| Ivan Lubogo | Senior Vice President of U.S. Sales |
| Andreas Henke | Executive Vice President and MD of Europe |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 4, 2024 | 10-Q | Quarterly Report |
| Nov 4, 2024 | 8-K | Current Report |
| Nov 1, 2024 | 144 | Filing |
| Oct 7, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Oct 4, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Sep 11, 2024 | 144 | Filing |
| Sep 9, 2024 | 144 | Filing |
| Sep 9, 2024 | 144 | Filing |